Luoxin Pharmaceuticals Group Stock Co., Ltd

Luoxin Pharmaceutical Group Stock Co., Ltd. is a healthcare conglomerate listed on the Shenzhen Stock Exchange since 2016, under the stock code 002793.SZ. The company is engaged in pharmaceutical research and development, manufacturing, sales, and healthcare services. With established R&D centers and manufacturing sites located in Shandong, Shanghai, and Chengdu, Luoxin Pharmaceutical aims to improve health outcomes by addressing unmet medical needs in areas such as gastrointestinal, respiratory, and oncology. The company boasts a competitive portfolio of products, particularly excelling in the gastrointestinal and respiratory sectors. Many of its offerings have been recognized in significant national science and technology initiatives, including the National Major New Product Plan and the National Torch Plan. Luoxin Pharmaceutical has consistently ranked among the Top 100 Chinese Pharmaceutical Enterprises and has received various accolades for its innovation and quality in pharmaceutical research and development.

Luoxin Pharmaceutical has a rich and competitive portfolio of products and the star products take the lead in GI and respiratory. Many products were listed in major science and technology projects, such as National Major New Product Plan, National Torch Plan as well as Major New Drug R&D. In addition, having been ranking among Top 100 Chinese Pharmaceutical Enterprises since 2006, and among Best Enterprises in Chinese Pharmaceutical R&D Pipelines since 2011, Luoxin Pharmaceutical was recognized as State Key High-tech Enterprise, State Technology Innovation Model Enterprise, National Industrial Quality Model Enterprise, and awarded with the 2nd prize in the State Sci. & Tech Progress many times.